“The Boob Bus” — An entrepreneur turns mammography into a road show. (Lassonde Entrepreneur Institute, University of Utah)
Radiation therapy before mastectomy for breast cancer reduced delays in reconstructive surgery. (University of Texas MD Anderson Cancer Center, JAMA Network Open)
A community outreach program showed promise for improving detection of Helicobacter pylori, a bacteria strongly associated with increased risk of stomach cancer. (Sylvester Comprehensive Cancer Center, Clinical Gastroenterology and Hepatology)
Angiotensin converting enzyme inhibitors did not reduce heart damage in patients taking anthracycline-containing chemotherapy for cancer. (American College of Cardiology)
An FDA advisory committee recommended accepting minimal residual disease as a primary endpoint for trials supporting accelerated approvals in multiple myeloma, potentially paving the way for the endpoint to become a standard for hematologic malignancies. (Endpoint News)
Does publicity surrounding celebrities’ cancer diagnoses increase the public’s fear of cancer and delay diagnoses? (STAT)
Amid growing concern and frustration with insurers’ prior authorization policies, more state governments are looking at legislation to streamline the process and reduce treatment delays. (Association for Clinical Oncology)
Combining genetic testing with a novel approach to testing individual drugs could provide a more accurate and rapid way to identify the best treatment for an individual patient with cancer. (BioSpace, Nature Medicine)
A potential strategy to improve the function and survival of CAR T cells might lead to more effective therapies that are beneficial for more types of cancer. (Children’s Hospital of Philadelphia, Stanford Medicine)
While one group focuses on making CAR T-cell therapy more effective, another looks at ways to make the treatment more affordable and accessible to patients with cancer. (MIT Technology Review)
Should alcohol have labels that warn about cancer risks? (New York Times)
-
Charles Bankhead is senior editor for oncology and also covers urology, dermatology, and ophthalmology. He joined MedPage Today in 2007. Follow
Please enable JavaScript to view the